首页> 外文会议>Computing in Cardiology >Interaction Between ECG and Genetic Markers of Coronary Artery Disease
【24h】

Interaction Between ECG and Genetic Markers of Coronary Artery Disease

机译:冠状动脉疾病心电图与遗传标志物的相互作用

获取原文

摘要

Coronary artery disease (CAD) is the main contributor to cardiovascular mortality in developed countries, making accurate diagnosis of utmost importance. We developed risk scores to assess CAD risk in a population without known cardiovascular disease by combining ECG and a genetic risk score (GRS) for CAD. We analysed data in 52,260 individuals in the UK Biobank study. ECG indices included heart rate, PR, QRS, QT and T-peak-to-T-end intervals, while we built the GRS from publicly available genome-wide association results for CAD that were derived in an independent population. In a training set (N = 39,195), the indices with the strongest CAD prognostic impact were the PR and QT intervals, and the GRS. When combined together into a Multivariate model, both the ECG markers and the GRS were independently associated with CAD. In an independent test set (N = 13,065), we then built three risk scores based on (1) ECG markers, (2) genetic data, and (3) a combination of ECG and genetic data, respectively. The hazard ratio (95% confidence interval) for CAD comparing high versus low-risk individuals was 6.5 (5.1 - 8.3),8.4 (6.4 - 10.8) and 8.4 (6.5 - 10.8) for the three risk scores, respectively. In conclusion, the inclusion of genetic markers into risk scores with ECG markers independently contributes to CAD risk prediction in a large population of individuals without known cardiovascular disease.
机译:冠状动脉疾病(CAD)是发达国家心血管死亡率的主要原因,准确诊断至关重要。我们通过组合ECG和CAD的遗传风险评分(GRS),在没有已知心血管疾病的情况下,在没有已知心血管疾病的情况下评估CAD风险的风险分数。我们分析了英国Biobank研究中的52,260人的数据。 ECG指数包括心率,PR,QRS,QT和T-Que-To-T-T-Tem Intervals,而我们从公共可用的基因组关联结果中建立了在独立人群中获得的CAD的GRS。在培训集(n = 39,195)中,具有最强的CAD预后影响的索引是PR和QT间隔,以及GRS。当组合成多变量模型时,ECG标记和GRS都与CAD独立相关。在一个独立的测试集(n = 13,065)中,我们分别基于(1)ECG标记,(2)遗传数据和(3)分别构建了三个风险评分,分别为ECG和遗传数据的组合。比较高与低风险个体的CAD的危险比(95%置信区间)分别为3.5(5.1 - 8.3),8.4(6.4 - 10.8)和8.4(6.5 - 10.8),适用于三个风险评分。总之,将遗传标志物包含在没有已知心血管疾病的情况下的大量个体中的CAD风险预测,将遗传标记物纳入风险评分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号